Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unison Capital is a leading independent private equity firm in East Asia, specializing in mid-market buyout opportunities in Japan and South Korea. Established in 1998, the firm has developed a significant vertical expertise in the healthcare sector, investing in pharmaceutical manufacturers, medical technology, and healthcare service providers. Through investment vehicles like Unison Capital Partners IV, the firm executes a hands-on operational value creation strategy, often focusing on market consolidation and the professionalization of family-owned businesses. Notable healthcare assets in their track record include Ayumi Pharmaceutical and the Community Healthcare Professionals (CHCP) platform. The firm operates primarily out of offices in Tokyo and Seoul, leveraging deep local networks to drive regional expansion for its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unison Capital Partners IV.